Fonte: Gynecologic Oncology. Unidade: FM
Assuntos: NEOPLASIAS OVARIANAS (EFICIÊNCIA;SEGURANÇA), QUIMIOTERAPIA ADJUVANTE (EFICIÊNCIA;SEGURANÇA), PROCEDIMENTOS CIRÚRGICOS OBSTÉTRICOS
ABNT
MIRANDA, Vanessa da Costa et al. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness. Gynecologic Oncology, v. 132, n. 2, p. 287-291, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.ygyno.2013.12.002. Acesso em: 12 nov. 2024.APA
Miranda, V. da C., Fêde, Â. B. de S., Anjos, C. H. dos, Silva, J. R. da, Sanchez, F. B., Bessa, L. R. da S., et al. (2014). Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness. Gynecologic Oncology, 132( 2), 287-291. doi:10.1016/j.ygyno.2013.12.002NLM
Miranda V da C, Fêde ÂB de S, Anjos CH dos, Silva JR da, Sanchez FB, Bessa LR da S, Carvalho J de P, Abdo Filho E, Freitas D de, Diz MDPE. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness [Internet]. Gynecologic Oncology. 2014 ; 132( 2): 287-291.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.ygyno.2013.12.002Vancouver
Miranda V da C, Fêde ÂB de S, Anjos CH dos, Silva JR da, Sanchez FB, Bessa LR da S, Carvalho J de P, Abdo Filho E, Freitas D de, Diz MDPE. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness [Internet]. Gynecologic Oncology. 2014 ; 132( 2): 287-291.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.ygyno.2013.12.002